Advanced search
Publication Cover
Leukemia & Lymphoma Volume 10, 1993 - Issue 3
Submit an article Journal homepage
38
Views
32
CrossRef citations to date
0
Altmetric
Original Article

Phase II Clinical Trial of Fludarabine in Chronic Lymphocytic Leukemia on a Weekly Low-Dose Schedule

A. Kemena The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA
,
S. O'brien The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA
,
H. Kantarjian The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA
,
L. Robertson The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA
,
C. Koller The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA
,
M. Beran The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA
,
E. Estey The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA
,
W. Plunkett The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA
,
S. Lerner The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA
&
M. J. Keating The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA
 show all
Pages 187-193 | Received 24 Oct 1992, Published online: 01 Jul 2009

References

  • Binit J. L., Catovsky D., Chandra P., Dighiero G., Montserrat E., Rai K. R., Sawitsky A. Chronic lymphocytic leukemia: Proposals for a revised prognostic staging system. Br. J. Haematol. 1981; 48: 365
  • Han T., Ezdinli E. Z., Shimaoka K., Desal D. V. Chlorambucil vs. combined chlorambucil-corticosteroid therapy in chronic lymphocytic leukemia. Cancer 1973; 31: 502
  • Sawitsky A., Rai K. R., Glidewell, Silver R. T. Cancer and Leukemia Group B. Comparison of daily versus intermittent chlorambucil and prednisone therapy in the treatment of patients with chronic lymphocytic leukemia. Blood 1977; 50: 1049
  • Idestrom K., Kimby E., Bjorkholm M. Treatment of chronic lymphocytic leukemia and well-differentiated lymphocytic lymphoma with continuous low- or intermittent high-dose prednimustine versus chlorambucil/prednisolone. Eur. J. Cancer 1982; 18: 1117
  • Montserrat E., Alcala A., Parody R. Treatment of chronic lymphocytic leukemia in advanced stages: a randomized trial comparing chlorambucil plus prednisone versus cyclophosphamide, vincristine, and prednisone. Cancer 1985; 56: 2369
  • Keller J. W., Knospe W. H., Raney M., Huguley C. M., Johnson L., Bartolucci A. A., Omura G. A. Treatment of chronic lymphocytic leukemia using chlorambucil and prednisone with or without cycle-active consolidation chemotherapy: Southeastern Cancer Study Group. Cancer 1986; 58: 1185
  • Keating M. J., Kantarjian H., O'Brien S., Koller C., Talpaz M., Schachner J., Childs C. C., Freireich E. J., McCredie K. B. Fludarabine: A new agent with marked cytoreductive activity in untreated chronic lymphocytic leukemia. J. Clin. Oncol. 1991; 9: 44
  • Keating M. J., Kantarjian H., Talpaz M., Redman J., Koller C., Barlogie B., Velasquez W., Plunkett W., Freireich E. J., McCredie K. B. Fludarabine: A new agent with major activity against chronic lymphocytic leukemia. Blood 1989; 74: 19
  • Kemena A., Keating M. J., Plunkett W. Plasma and cellular bioavailability of oral fludarabine. Blood 1991; 77: 52a, (199).
  • Plunkett W., Adams T., Keating M. Pharmacologic basis for the therapeutic index of high-dose are-C: Implications for combinations. Proc. Am. Assoc. Cancer Res. 1986; 27: 174, (688).
  • Grever M. R., Kopecky K. J., Coltman C. A., Files J. C., Greenberg B. R., Hutton J. J., Talky R., Von Hoff D. D., Balcerzak S. P. Fludarabine monophosphate: a potentially useful agent in chronic lymphocytic leukemia. Nouv. Rev. Fr. Hematol. 1988; 30: 451
  • Keating M. J., Kantarjian H., Talpaz M., Redman J., McCredie K. B. Fludarabine therapy in chronic lymphocytic leukemia (CLL). Noun Rev. Fr. Hematol. 1988; 30: 461
  • Hutton J. J., Von Hoff D. D., Kuhn J., Phillips J., Hersh M., Clark G. Phase I clinical investigation of 9–b˜-D-arabinofuranosyl-2–fluoroadenine 5′-monophosphate aNSC 312887), a new purine antimetabolite. Cancer Res. 1984; 44: 1183
  • Srever M. R., Kraut E. H., Neidhart J. A., Malspeis L. 2-Fluoroara-AMP: A phase I clinical investigation. Invest. New Drugs 1984; 2: 116
  • Danhauser L., Plunkett W., Keating M., Cabanillas F. 9–b˜-D-Arabinofuranosyl-2–fluoroadenine 5′-monophosphate pharmacokinetics in plasma and tumor cells of patients with relapsed leukemia and lymphoma. Cancer Chemother. Pharmacol. 1986; 18: 145

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.